Torino ALS Center (CRESLA)

University of Torino

The Torino ALS Center (CRESLA) performs basic and clinical research, while at the same time providing care for ALS patients.

Cresla_footer
University of Torino

Our centre is based in the largest public hospital in Italy (the “Città della Salute e della Scienza” hospital of Torino). We follow about 350 patients each year, both locally and nationwide. We have a diagnostic laboratory and a molecular genetics laboratory. Our scientific studies include both clinical and basic research of ALS. In the last decade, we have participated in 5 large international randomized clinical trials on innovative drugs in ALS. We have a multidisciplinary group and a daily ALS clinic. We also provide psychological, neuropsychological and neurophysiological services.

Contact
Location
University of Turin, Turin, Via Cherasco 15, 10126, Torino, Italy

Our Specialists

Adriano Chiò

Professor of Neurology

Adriano Chiò is a neurologist currently working in Torino, Italy. He is […]

Adriano Chiò
Current trials
Active
Phase ii

RT001 in Amyotrophic Lateral Sclerosis

Industry trial
In this phase 2 trial, we will study the safety and efficacy of the compound RT001 in people living with ALS. This clinical trial is sponsored by Retrotope Inc.
Read more
Active
Phase iii

ALXN1210-ALS-308 trial

Industry trial
This phase 3 trial aims to study the safety and efficacy of the drug ‘ravulizumab’ in people living with ALS. To register for this study, you should contact your local ALS centre or treating physician.
Read more
Active
Phase iii

VALOR study

Industry trial
Biogen is conducting a clinical trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS) with a SOD1 gene mutation.
Read more
Recruiting
Phase iii

TUDCA-ALS

Investigator initiated trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more